A Single Dose of Vero Cell-Derived Japanese Encephalitis (JE) Vaccine (Ixiaro) Effectively Boosts Immunity in Travelers Primed With Mouse Brain-Derived JE Vaccines

Emergence of Genotype I of Japanese Encephalitis Virus as the Dominant Genotype in Asia

(2011) X.-L. Pan et al.   JOURNAL OF VIROLOGY

Long term immunity following a booster dose of the inactivated Japanese Encephalitis vaccine IXIARO®, IC51

(2011) Susanne Eder et al.   VACCINE

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®

(2011) Elisabeth Schuller et al.   VACCINE

Genotype V Japanese Encephalitis Virus Is Emerging

(2011) Ming-Hua Li et al.   PLoS Neglected Tropical Diseases

Japanese Encephalitis in Travelers from Non-Endemic Countries, 1973–2008

(2010) Susan L. Hills et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Japanese encephalitis: update on vaccines and vaccine recommendations

(2010) A Wilder-Smith et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Adverse event reports following Japanese encephalitis vaccination in the United States, 1999–2009

(2010) Nicole P. Lindsey et al.   VACCINE

Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO® (IC51), in 6 months of follow-up

(2010) Katrin Dubischar-Kastner et al.   VACCINE

Long-term immunity and immune response to a booster dose following vaccination with the inactivated Japanese encephalitis vaccine IXIARO®, IC51

(2010) Katrin Dubischar-Kastner et al.   VACCINE

Japanese Encephalitis in Travelers: Review of Cases and Seasonal Risk

(2009) Mads R. Buhl et al.   JOURNAL OF TRAVEL MEDICINE

Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX®1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study

(2009) A. Kaltenböck et al.   VACCINE

Randomized, Double‐Blind, Placebo‐Controlled Phase 3 Trial of the Safety and Tolerability of IC51, an Inactivated Japanese Encephalitis Vaccine

(2008) E. Tauber et al.   JOURNAL OF INFECTIOUS DISEASES

Effect of genomic variation in the challenge virus on the neutralization titres of recipients of inactivated JE vaccines – Report of a collaborative study on PRNT50 assays for Japanese encephalitis virus (JE) antibodies

(2007) Morag Ferguson et al.   BIOLOGICALS